Embracing the New Era of Immunotherapy in Gastric Cancer Treatment
Advanced gastric cancer still presents a grim outlook, typically yielding a median survival rate of approximately 12 to 15 months. Recently, immune checkpoint inhibitors have emerged as a promising standard treatment for various malignancies, including advanced gastric cancer. They have shown signif...
| الحاوية / القاعدة: | South African Gastroenterology Review |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
In House Publications
2024
|
| الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182387330&partnerID=40&md5=7d1efd0df491f5c8afbc75fd971cca9c |